Penn State to utilize WElkins' brain cooling technology to explore "revolutionary step" in the treatment and prevention of sports-related concussions
WElkins, LLC is excited to share Penn State's announcement today of a groundbreaking new research program into the effects of brain cooling on sports-related concussion. The Principal Investigator, Semyon Slobounov -- Professor of Kinesiology and Director of the Penn State Center for Sport Concussion Research and Service -- studies sports-related traumatic brain injuries using advanced virtual reality and brain imaging tools. Now, with support from WElkins and Spartan Medical, he is determined to learn what more can be done about a problem that continues to arise in athletes of all ages, despite advanced testing and updated regulations and protocols.
Agreement Covers Sale of Medical, Athletic, and Industrial Products in the United States
ROSEVILLE, CA, October 9, 2012 — WElkins, LLC, which recently received U.S. Food and Drug Administration (FDA) clearance of its EMT and ICU Temperature Management Systems, today announced the signing of a sales and distribution agreement with Spartan Medical, Inc., a leading provider of best-in-class advanced medical solutions. Under the agreement, Spartan Medical will have exclusive rights to sell and distribute WElkins’ microenvironment cooling products to the U.S. Government, including the Department of Defense (DoD) and Department of Veterans Affairs (VA).
New device enables ultra-early, non-invasive therapeutic hypothermia in the field
ROSEVILLE, CA, August 23, 2012 — WElkins, LLC today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its EMT/ICU Temperature Management System. The EMT/ICU System provides hospitals and emergency care givers a means of reducing and controlling patient temperature in a safe, non-invasive, and effective way across the continuum of care—from the critical minutes after an injury thru to the ICU and recovery. Therapeutic cooling is among the most potent interventions for hypoxic-ischemic injury, limiting tissue damage by reducing oxygen metabolism and inflammation, while maintaining cell membrane integrity. The System includes a lightweight, portable cooling unit for pre-hospital induction of therapeutic cooling, i.e. immediately after return of spontaneous circulation (ROSC), which can be crucial to patient survival and recovery.